Catalyst Clinical Research Acquires Genpro Research
July 20, 2023
Catalyst Clinical Research, a Wilmington, North Carolina-based CRO and portfolio company of QHP Capital, has acquired Genpro Research, a Massachusetts-based clinical research organization with staff in the US, India, and Ireland. The deal adds more than 120 India-based team members and strengthens Catalyst's capabilities in biometrics/biostatistics, medical writing, real-world evidence (RWE)/HEOR, and AI-enabled automation.
- Buyers
- Catalyst Clinical Research
- Targets
- Genpro Research
- Platforms
- Catalyst Clinical Research
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Worldwide Clinical Trials Acquires Catalyst Clinical Research
February 17, 2026
Healthcare Services
Worldwide Clinical Trials completed its acquisition of oncology CRO Catalyst Clinical Research, expanding Worldwide’s oncology capabilities, biometrics, and functional service provider (FSP) offerings. The combined organization will operate with a workforce of approximately 4,400 employees across more than 70 countries, and financial terms were not disclosed.
-
Catalyst Clinical Research Merges with Ce3, Inc.
August 5, 2020
Healthcare Services
Catalyst Clinical Research, a NovaQuest-backed CRO headquartered in Wilmington, North Carolina, has merged with Ce3, Inc., an early-phase oncology-focused CRO based in Clinton, Connecticut. The transaction combines Ce3's 15+ years of oncology expertise with Catalyst's broader clinical development and technology capabilities to create a next-generation oncology-focused CRO (add-on to Catalyst's NovaQuest-backed platform).
-
Catalyst Clinical Research Acquires Aptus Clinical
May 4, 2022
Healthcare Services
Catalyst Clinical Research, a portfolio company of NovaQuest Capital Management, has acquired U.K.-based Aptus Clinical to accelerate Catalyst's European expansion and broaden its oncology and early-phase clinical services. The deal creates a multi-region CRO operating across North America and Europe, increases Catalyst's patient reach by nearly 600 and lifts combined headcount to more than 800.
-
GHO Capital Acquires Genesis Research
November 16, 2021
Healthcare Services
London-based GHO Capital Partners has acquired Genesis Research, a Hoboken, New Jersey–headquartered provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services. The transaction, which follows a prior recapitalization by Rallyday Partners, gives Genesis additional capital and European market expertise to pursue global expansion and adjacent capability growth.
-
Network Partners Acquires The FlexPro Group, LLC
March 31, 2021
Healthcare Services
Network Partners, a Warsaw, Indiana-based life sciences professional services firm, has acquired The FlexPro Group, LLC, a Greater Philadelphia project management consulting firm focused on the life sciences. The deal adds FlexPro's 40+ consultants to Network Partners' ~175-member team to expand regulatory, project management and supply chain optimization capabilities for pharmaceutical and biotechnology clients.
-
Cressey & Company and Sunstone Partners Make Growth Investment in ProgenyHealth
May 20, 2025
Healthcare Services
ProgenyHealth, a Plymouth Meeting, Pennsylvania–based leader in maternity and NICU care management, received a significant growth investment from Cressey & Company alongside existing investor Sunstone Partners. The capital and Cressey's healthcare expertise will support ProgenyHealth’s continued expansion of its tech-enabled maternity and NICU care management services and platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.